Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

COVID-19

Free Subscription 19.02.2024 1 Am J Obstet Gynecol 1 Antiviral Res 3 BMJ 1 Clin Infect Dis 5 Infect Control Hosp Epidemiol 2 Int J Infect Dis 2 J Infect 7 J Med Virol 1 J Virol 1 JAMA 1 Lancet 1 Lancet Infect Dis 1 N Engl J Med 1 Nature 1 Travel Med Infect Dis

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Obstet Gynecol

1. BRUNO AM, Sandoval GJ, Hughes BL, Grobman WA, et al
   Postpartum pharmacologic thromboprophylaxis and complications in a US cohort.
   Am J Obstet Gynecol. 2024 Feb 8:S0002-9378(23)00815.
   PubMed         Abstract available
   
   

   
   Antiviral Res

2. JIAO Z, Wang P, Hu X, Chen Y, et al
   Feline infectious peritonitis virus ORF7a is a virulence factor involved in inflammatory pathology in cats.
   Antiviral Res. 2024;222:105794.
   PubMed         Abstract available
   
   

   
   BMJ

3. MELLO MM, Jiang D, Platt E, Moran-McCabe K, et al
   Legal infrastructure for pandemic response: lessons not learnt in the US.
   BMJ. 2024;384:e076269.
   PubMed        
   
   
4. 
   Seven days in medicine: 31 Jan to 6 Feb 2024.
   BMJ. 2024;384:q299.
   PubMed        
   
   
5. IACOBUCCI G
   Long covid: Online rehabilitation can improve quality of life, study reports.
   BMJ. 2024;384:q346.
   PubMed        
   
   

   
   Clin Infect Dis

6. HOFMEYER KA, Ventura CL, Armstrong KL, Houchens CR, et al
   Project NexGen: Developing the Next Generation of COVID-19 Vaccines and Therapeutics to Respond to the Present and Prepare for the Future.
   Clin Infect Dis. 2024 Feb 13:ciae073. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Infect Control Hosp Epidemiol

7. MOST ZM, Phillips B, Sebert ME
   Healthcare-associated respiratory viral infections after discontinuing universal masking.
   Infect Control Hosp Epidemiol. 2024;45:247-249.
   PubMed         Abstract available
   
   
8. VALEK AL, Srinivasa VR, Ayres AM, Cheung S, et al
   Incidence and transmission associated with respiratory viruses in an acute care facility: An observational study.
   Infect Control Hosp Epidemiol. 2024 Feb 14:1-3. doi: 10.1017/ice.2024.
   PubMed         Abstract available
   
   
9. HOWARD-ANDERSON JR, Gottlieb LB, Beekmann SE, Polgreen PM, et al
   Implementation of contact precautions for multidrug-resistant organisms in the post-COVID-19 pandemic era: An updated national Emerging Infections Network (EIN) survey.
   Infect Control Hosp Epidemiol. 2024 Feb 14:1-6. doi: 10.1017/ice.2024.
   PubMed         Abstract available
   
   
10. STROBL R, Misailovski M, Blaschke S, Berens M, et al
    Differentiating patients admitted primarily due to coronavirus disease 2019 (COVID-19) from those admitted with incidentally detected severe acute respiratory syndrome corona-virus type 2 (SARS-CoV-2) at hospital admission: A cohort analysis of German
    Infect Control Hosp Epidemiol. 2024 Feb 14:1-8. doi: 10.1017/ice.2024.
    PubMed         Abstract available
    
    
11. BARTSCH SM, Weatherwax C, Martinez MF, Chin KL, et al
    Cost-effectiveness of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) testing and isolation strategies in nursing homes.
    Infect Control Hosp Epidemiol. 2024 Feb 15:1-8. doi: 10.1017/ice.2024.
    PubMed         Abstract available
    
    

    
    Int J Infect Dis

12. DOHERTY TM, Pasquale AD, Finnegan G, Lele J, et al
    Sustaining the momentum for adult vaccination post-COVID-19 to leverage the global uptake of life-course immunisation: a scoping review.
    Int J Infect Dis. 2024 Feb 12:S1201-9712(24)00031.
    PubMed         Abstract available
    
    
13. TANG Q, Xie X, Peng L, Yang L, et al
    Pre-existing Renal Graft Dysfunction As A Major Risk Factor for SARS-CoV-2 Omicron Variant Pneumonia: a Post-Infection Cross-Sectional Study of 312 Immunosuppressed Renal Transplant Recipients.
    Int J Infect Dis. 2024 Feb 13:S1201-9712(24)00030.
    PubMed         Abstract available
    
    

    
    J Infect

14. XIE L, Luo G, Yang Z, Wu WC, et al
    The clinical outcome of COVID-19 is strongly associated with microbiome dynamics in the upper respiratory tract.
    J Infect. 2024 Feb 9:S0163-4453(24)00036-7. doi: 10.1016/j.jinf.2024.
    PubMed         Abstract available
    
    
15. KALKERI R, Zhu M, Cloney-Clark S, Plested JS, et al
    Altered IgG4 Antibody Response to Repeated mRNA versus Recombinant Protein SARS-CoV-2 Vaccines.
    J Infect. 2024 Feb 13:106119. doi: 10.1016/j.jinf.2024.106119.
    PubMed        
    
    

    
    J Med Virol

16. ZENG G, Zhang Z, Wang L, Li J, et al
    Risk factors of long COVID 6-12 months after infection with the Omicron variant among nonhospitalized patients.
    J Med Virol. 2023;95:e29235.
    PubMed        
    
    
17. ZHAN H, Xie Y, Liu Y, Cheng L, et al
    Omicron BA.4/5 neutralization and cell-mediated immune responses in relation to baseline immune status and breakthrough infection among PLWH: A follow-up cohort study.
    J Med Virol. 2024;96:e29446.
    PubMed         Abstract available
    
    
18. KIM D, Kim M, Kim J, Baek K, et al
    A mouse xenograft long-term replication yields a SARS-CoV-2 Delta mutant with increased lethality.
    J Med Virol. 2024;96:e29459.
    PubMed         Abstract available
    
    
19. KWOK KO, Wei WI, Mcneil EB, Tang A, et al
    Comparative analysis of symptom profile and risk of death associated with infection by SARS-CoV-2 and its variants in Hong Kong.
    J Med Virol. 2024;96:e29326.
    PubMed         Abstract available
    
    
20. CENAT JM, Farahi SMMM, Dalexis RD, Yaya S, et al
    COVID-19 vaccine uptake, conspiracy theories, and health literacy among Black individuals in Canada: Racial discrimination, confidence in health, and COVID-19 stress as mediators.
    J Med Virol. 2024;96:e29467.
    PubMed         Abstract available
    
    
21. SADAT LARIJANI M, Javadi A, Eskandari SE, Doroud D, et al
    The impact of ABO blood types on humoral immunity responses and antibody persistency after different COVID-19 vaccine regimens.
    J Med Virol. 2024;96:e29438.
    PubMed         Abstract available
    
    
22. COLSON P, Delerce J, Pontarotti P, Devaux C, et al
    Resistance-associated mutations to the anti-SARS-CoV-2 agent nirmatrelvir: Selection not induction.
    J Med Virol. 2024;96:e29462.
    PubMed         Abstract available
    
    

    
    J Virol

23. LI Z, Lai Y, Qiu R, Tang W, et al
    Hyperacetylated microtubules assist porcine deltacoronavirus nsp8 to degrade MDA5 via SQSTM1/p62-dependent selective autophagy.
    J Virol. 2024 Feb 14:e0000324. doi: 10.1128/jvi.00003.
    PubMed         Abstract available
    
    

    
    JAMA

24. RUBIN R
    When It Comes to SARS-CoV-2 Clearance, People Who are Immunocompromised Are Not All Alike.
    JAMA. 2024 Feb 14. doi: 10.1001/jama.2024.1014.
    PubMed        
    
    

    
    Lancet

25. WALLER BY, Joseph VA, Keyes KM
    Racial inequities in homicide rates and homicide methods among Black and White women aged 25-44 years in the USA, 1999-2020: a cross-sectional time series study.
    Lancet. 2024 Feb 8:S0140-6736(23)02279-1. doi: 10.1016/S0140-6736(23)02279.
    PubMed         Abstract available
    
    

    
    Lancet Infect Dis

26. MACHKOVECH HM, Hahn AM, Garonzik Wang J, Grubaugh ND, et al
    Persistent SARS-CoV-2 infection: significance and implications.
    Lancet Infect Dis. 2024 Feb 7:S1473-3099(23)00815.
    PubMed         Abstract available
    
    

    
    N Engl J Med

27. VERMERSCH P, Granziera C, Mao-Draayer Y, Cutter G, et al
    Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
    N Engl J Med. 2024;390:589-600.
    PubMed         Abstract available
    
    

    
    Nature

28. 
    The immune markers that predict who can keep SARS-CoV-2 in check.
    Nature. 2024 Feb 13. doi: 10.1038/d41586-024-00411.
    PubMed        
    
    

    
    Travel Med Infect Dis

29. GAGLIARDINI R, Giacomelli A, Bozzi G, D'Arminio Monforte A, et al
    Impact of COVID-19 pandemic on retention in care of native and migrant people with HIV in the ICONA cohort.
    Travel Med Infect Dis. 2024;58:102691.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.